PACB
Pacific Biosciences Of California
$2.25
+$0.14 (+6.64%)Oct 26, 2026
Key metrics
The numbers that frame PACB today
- Market cap
- $699.37M
- Gross margin
- 36.4%
- EV / Sales
- 8.4
- ROIC
- -12%
- Div yield
- 0%
- 52wk Low
- $1.07
- 52wk High
- $3.44
Growth
Revenue and earnings trend for PACB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PACB
Is Pacific Biosciences Of California a good buy?
No. Pacific Biosciences Of California has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Pacific Biosciences Of California is selling at a high price.
What is the market capitalization of PACB?
Pacific Biosciences Of California's market capitalization is $699.37M.
What is the 52-week high for PACB stock?
The 52-week high for Pacific Biosciences Of California is $3.44. The current close of $2.25 is 34.5% below that high.
What is the 52-week low for PACB stock?
The 52-week low for Pacific Biosciences Of California is $1.07. The current close of $2.25 is 110.3% above that low.
Does PACB stock pay dividends?
Pacific Biosciences Of California does not currently show a dividend per share in the company data.